Cortland Associates’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1M Sell
120,487
-3,941
-3% -$1.09M 4.61% 10
2025
Q4
$34.2M Sell
124,428
-2,063
-2% -$578K 4.32% 10
2025
Q3
$36.5M Sell
126,491
-86
-0.1% -$25.4K 4.31% 10
2025
Q2
$41.8M Sell
126,577
-4
-0% -$1.29K 4.88% 8
2025
Q1
$41.6M Sell
126,581
-363
-0.3% -$109K 5% 8
2024
Q4
$35.1M Sell
126,944
-48,495
-28% -$15.5M 3.99% 12
2024
Q3
$60.8M Sell
175,439
-2,084
-1% -$717K 7.38% 3
2024
Q2
$58.7M Sell
177,523
-1,185
-0.7% -$409K 7.42% 3
2024
Q1
$64.9M Sell
178,708
-1,960
-1% -$645K 8.4% 2
2023
Q4
$54.1M Sell
180,668
-609
-0.3% -$178K 7.92% 4
2023
Q3
$51.9M Buy
181,277
+38,346
+27% +$10.9M 8.13% 2
2023
Q2
$40.1M Sell
142,931
-6,189
-4% -$1.61M 6.46% 5
2023
Q1
$38.1M Sell
149,120
-39,542
-21% -$11.5M 6.07% 7
2022
Q4
$62.5M Sell
188,662
-1,686
-0.9% -$533K 10.36% 2
2022
Q3
$52.8M Sell
190,348
-51,308
-21% -$14.4M 9.4% 2
2022
Q2
$63.7M Sell
241,656
-31,090
-11% -$8.01M 10.53% 1
2022
Q1
$65.4M Sell
272,746
-10,956
-4% -$2.56M 8.33% 3
2021
Q4
$65.1M Buy
283,702
+6,239
+2% +$1.33M 6.77% 4
2021
Q3
$55.5M Buy
277,463
+66,535
+32% +$14.5M 6.11% 7
2021
Q2
$50M Sell
210,928
-609
-0.3% -$152K 5.23% 7
2021
Q1
$51.1M Sell
211,537
-4,286
-2% -$955K 5.83% 6
2020
Q4
$44.9M Sell
215,823
-2,378
-1% -$466K 5.41% 7
2020
Q3
$37M Sell
218,201
-98,711
-31% -$17.4M 4.96% 9
2020
Q2
$59.5M Buy
316,912
+686
+0.2% +$130K 8.77% 3
2020
Q1
$56M Buy
316,226
+8,159
+3% +$1.58M 10.51% 3
2019
Q4
$63M Buy
308,067
+23,569
+8% +$4.32M 8.91% 3
2019
Q3
$43.2M Buy
284,498
+36,585
+15% +$5.95M 7.64% 5
2019
Q2
$39.1M Sell
247,913
-3,474
-1% -$544K 6.18% 7
2019
Q1
$40.4M Buy
251,387
+9,116
+4% +$1.66M 6.53% 7
2018
Q4
$46M Buy
+242,271
New +$50.5M 8.35% 3

Other funds holding CI

Cortland Associates's CI Position: Q1 2026 in Review

Cortland Associates reduced its Cigna (CI) stake by 3.2% in Q1 2026, selling an estimated $1.09M and leaving 120,487 shares worth $32.1M. The position accounts for 4.61% of the portfolio, ranked #10.

Cortland Associates first reported a position in CI in Q4 2018 and has held it in 30 quarters since. The position peaked at $65.4M in Q1 2022. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Cortland Associates held 120,487 shares of Cigna worth $32.1M as of Q1 2026.
  • Cortland Associates sold 3,941 Cigna shares in Q1 2026, an estimated $1.09M.
  • Cigna made up 4.61% of Cortland Associates's portfolio in Q1 2026, its #10 holding.
  • Cortland Associates first reported a position in Cigna in Q4 2018 and has held it in 30 quarters since.
  • Cortland Associates's Cigna position peaked at $65.4M in Q1 2022.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Cortland Associates's 13F filing for Q1 2026, filed 30 Apr 2026.